Impact of Obesity and Smoking on Psoriasis Presentation and Management
Open Access
- 1 December 2005
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 141 (12), 1527-1534
- https://doi.org/10.1001/archderm.141.12.1527
Abstract
Objective To study the impact of obesity and smoking on psoriasis. Design Cross-sectional study. Setting University of Utah Department of Dermatology clinics. Patients A case series of patients with psoriasis enrolled in the prospective Utah Psoriasis Initiative (UPI) (which carefully performs phenotyping of patients with psoriasis) was compared with 3 population databases: the Behavioral Risk Factor Surveillance System of the Utah population, the 1998 patient-member survey from the National Psoriasis Foundation, and 500 adult patients who attend our clinics and do not have psoriasis (nonpsoriatic population). Results The prevalence of obesity in patients within the UPI population was higher than that in the general Utah population (34% vs 18%; P<.001) and higher than that in the nonpsoriatic population attending our clinics. Assessment of body image perception with a standardized diagram in the UPI group resulted in the median body image score of normal weight at 18 years of age and the onset of psoriasis, but it transitioned to overweight at the time of enrollment in the UPI. Thus, obesity appears to be the consequence of psoriasis and not a risk factor for onset of disease. We did not observe an increased risk for psoriatic arthritis in patients with obesity; furthermore, obesity did not positively or negatively affect the response or the adverse effects of topical corticosteroids, light-based treatments, and systemic medications. The prevalence of smoking in the UPI population was higher than in the general Utah population (37% vs 13%; P<.001) and higher than in the nonpsoriatic population (37% vs 25%; P<.001). We found a higher prevalence of smokers in the obese population within the UPI than in the obese population within the Utah population (25% vs 9%; P<.001). Conclusions Patients with psoriasis attending the University of Utah Dermatology Clinics were more likely to be obese and to smoke compared with nonpsoriatic patients and more likely to be obese compared with other large cohorts with psoriasis. Smoking appears to have a role in the onset of psoriasis, but obesity does not. The high prevalence of obesity and smoking in a psoriasis cohort has not been previously noted; if confirmed, it supports the prediction that a significant portion of patients with psoriasis will have the comorbid conditions and public health issues of those with obesity and smoke.Keywords
This publication has 32 references indexed in Scilit:
- Correlates of physical activity in urban Midwestern LatinasAmerican Journal of Preventive Medicine, 2003
- Physical Activity, Obesity, and the Incidence of Type 2 Diabetes in a High-Risk PopulationAmerican Journal of Epidemiology, 2003
- Why target sedentary adults in primary health care? Baseline results from the Waikato Heart, Health, and Activity StudyPreventive Medicine, 2003
- Medical morbidity in binge eating disorderInternational Journal of Eating Disorders, 2003
- Binge eating disorder and obesity in 2003: Could treating an eating disorder have a positive effect on the obesity epidemic?International Journal of Eating Disorders, 2003
- Prevalence of Obesity, Diabetes, and Obesity-Related Health Risk Factors, 2001JAMA, 2003
- The Continuing Epidemics of Obesity and Diabetes in the United StatesJama-Journal Of The American Medical Association, 2001
- Self‐Reported Body Mass Index and Health‐Related Quality of Life: Findings from the Behavioral Risk Factor Surveillance SystemObesity Research, 2001
- The Continuing Epidemic of Obesity in the United StatesJama-Journal Of The American Medical Association, 2000
- The Spread of the Obesity Epidemic in the United States, 1991-1998JAMA, 1999